Schedule a consultation with Metier Clinical Services today and lets build a strategy that works for youmind, body, and metabolism
Saxenda (liraglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist administered via subcutaneous injection for weight management in adults with obesity or overweight with weight-related comorbidities
Key factors include third-party testing documentation, proper storage and shipping practices, reputation within research communities, and transparent business practices
While most side effects are manageable, persistent reactions may indicate you need a slower dose escalation or a different medication approach
Wegovy, however, has a longer clinical track record, more published long-term safety data, and the unique cardiovascular risk reduction approval
Increased masked hypertension prevalence in patients with polycystic ovary syndrome (PCOS)